Acetate vs TFA: peptide salt forms
Two vials labelled “BPC-157 5mg” can contain measurably different amounts of peptide. The difference is often the counter-ion — the acid left behind when the peptide is isolated as a salt.
Why a peptide is a salt, not a neutral molecule
Solid-phase synthesis ends with cleavage from the resin in strong acid, almost always trifluoroacetic acid. Purification by reversed-phase HPLC then runs in water/acetonitrile with TFA as the ion-pairing agent. When the purified fractions are frozen and dried, the peptide is left as a trifluoroacetate salt: the basic residues carry a positive charge and TFA provides the counter-ions.
Some suppliers stop there and ship the TFA salt. Others run an ion-exchange step to convert the material to acetate, which is the more common form for laboratory work. Both are legitimate; what matters is that the form is stated and that the specification matches it.
What the counter-ion changes
| Property | Effect of the salt form | Why it matters |
|---|---|---|
| Molecular weight | Each TFA counter-ion adds about 114.02 Da; each acetate about 60.05 Da | The mass you measure by MS and the mass on the COA must refer to the same species |
| Peptide content | A 10 mg fill of a heavy salt contains less free peptide than the same fill of a light salt | Weighing “10 mg” does not give 10 mg of peptide |
| Solution pH | Residual TFA lowers the pH of the reconstituted solution | Assay buffers and pH-sensitive work can shift |
| Assay behaviour | TFA is not inert in cell-based systems at higher concentrations | An assay can be affected by the counter-ion rather than the peptide |
| Hygroscopicity | Salt form and residual moisture affect how quickly the powder takes up water | Weighing accuracy and stability during handling |
Doing the arithmetic
Take a peptide with a free-base molecular weight of 1000.0 g/mol, supplied as a di-TFA salt. The salt mass is 1000.0 + (2 × 114.02) = 1228.04 g/mol, so 10 mg of powder contains 10 × (1000.0 / 1228.04) = 8.14 mg of free peptide. The same peptide as a di-acetate salt has a mass of 1000.0 + (2 × 60.05) = 1120.1 g/mol, and 10 mg of that powder contains 8.93 mg of free peptide.
That is roughly a 10% difference in the amount of peptide in the vial — enough to matter when you are preparing a stock solution to a target concentration, and enough to make two quotations incomparable if you only look at the nominal fill.
What a COA should state
- The salt form explicitly — “as acetate”, “as trifluoroacetate”, or the sodium form where relevant.
- The molecular weight basis — free base or salt — so the MS result can be interpreted.
- Peptide content by a stated method (typically nitrogen determination or amino acid analysis), not only net weight.
- Residual TFA where the material is a TFA salt or where the buyer sets a limit; the tested value should come with the method.
- Water content by Karl Fischer, because it dilutes peptide content in the same way the counter-ion does.
Specification clauses worth adding
Name the form in the specification annex, not just in the product title. Require that the batch COA state the form and the peptide content, and require a maximum for residual TFA if your work is sensitive to it. If you are switching suppliers and the new material is a different salt, treat it as a new material: solubility, pH and assay behaviour may all shift, and a method transfer is a revalidation, not a formality.
Practical notes
- Ask for the form before you compare price per vial; the cheapest offer is often the heaviest salt.
- For cell-based work, acetate is generally the easier starting point; confirm with your own assay rather than assuming.
- Record the form in your internal inventory — two forms of the same peptide are not interchangeable stock.
- If a certificate states a molecular weight that matches neither the free base nor a plausible salt, ask which species was measured.
Editor's take
Counter-ion content is invisible in a purity number and visible in your cost per milligram. Acetate and TFA are different materials with different masses; the label should say which.
Limitations
This guide describes methods and interpretation, not acceptance limits. Limits must come from your own specification and, where applicable, the relevant pharmacopoeial monograph. No testing was performed by the author for this page.
Products referenced in this guide
Related reading & products
- How to verify peptide purity — what HPLC and MS each prove
- COA red flags — spotting a recycled certificate
- Reconstitution practice — solvent choice and concentration math
- Reading a sequence and its molecular weight — residue arithmetic and terminal modifications
- Net peptide content and cost per mg — fill weight vs peptide mass
- Purification and salt conversion — how the counter-ion is actually exchanged
- How to read a COA — the fields that matter
- All knowledge guides